Search Results
Jun 15, 2026, 02:34 ET Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP
6, 2026CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Immutep filed an SEC Form-K on January 30, 2026 that its TACTI-004 trial of eftilagimod alfa ("efti") was showing "strong operational progress." Despite this claim, the Company
More news about: DJS Law Group LLP
Jun 15, 2026, 02:34 ET IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm
and misleading statements to the market. Immutep concealed the results of its TACTI-004 trial of eftilagimod alfa's ("efti"). The Company claimed in a Form-K filed with the SEC on January 30, 2026, that the trial was demonstrating "strong operational progress." The Company was aware at that time that the
More news about: The Schall Law Firm
Jun 15, 2026, 02:30 ET Hey World, Meet WOZOYO - With Tech That Helps You Find Your Flow
and smooth surfaces, every element is thoughtfully crafted to deliver an intuitive user experience. Inspired by the Wozoyo logo, a distinctive open form 'O' is subtly integrated across the product ecosystem, creating a cohesive visual identity that balances aesthetics with functionality. Designed in
More news about: Wozoyo
Jun 15, 2026, 01:02 ET Shield AI and Destinus demonstrate autonomous strike and teaming capabilities on an interceptor system in full-mission flight exercise
Destinus Hornet is a multi-role autonomous platform capable of counter-UAS, strike, reconnaissance, data relay, and security operations. Hornet systems form part of a broader layered air-defense architecture designed to protect high-value sites and critical infrastructure.The Hivemind AI pilot enables
More news about: Shield AI
Jun 14, 2026, 22:00 ET Haivivi BubblePal: Redefine Playtime with Screen-Free AI Plush Toy for Modern Families
emotional changes, achieving scientific parenting.Having won wide recognition from over 250,000 households, Haivivi BubblePal reimagines the form of smart playthings. If you are looking for safe, educational and screen-free kid toys, this AI plush toy will bring brand-new joy and growth to your
More news about: Haivivi (Yueran Innovation)
Jun 14, 2026, 17:00 ET Concept Study Identifies Potential Refining Pathway at Shaakichiuwaanaan to Battery-Grade Lithium Carbonate
condition, results of operations and growth prospects. Readers should review the detailed risk discussion in the Company's most recent Annual Information Form filed on SEDAR+, for a fuller understanding of the risks and uncertainties that affect the Company's business and operations.Although the Company
More news about: PMET Resources Inc.
Jun 14, 2026, 13:06 ET Die Menarini Group präsentiert auf dem Kongress der European Hematology Association (EHA) 2026 Daten aus der Phase-3-Studie SENTRY zur Kombination von Selinexor und Ruxolitinib bei Myelofibrose
bahnbrechende Therapien zur Verfügung zu stellen, sind stärker denn je."Informationen zur Myelofibrose (MF)Myelofibrose (MF) ist eine Form von Blutkrebs, die zu einer Gruppe von Erkrankungen gehört, die als myeloproliferative Neoplasien (MPN) bezeichnet werden. Diese Erkrankungen werden
More news about: Menarini Industrie Farmaceutiche Riunite
Jun 14, 2026, 10:44 ET Rosen Law Firm Encourages FLOW Cryptocurrency Investors to Inquire About Securities Class Action Investigation
https://rosenlegal.com/submit-form/?case_id=56767 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for
More news about: THE ROSEN LAW FIRM, P. A.
Jun 14, 2026, 09:46 ET Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
https://rosenlegal.com/submit-form/?case_id=56641 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Jun 14, 2026, 09:36 ET SAMARITAN'S PURSE EBOLA TREATMENT CENTERS OPEN IN THE EPICENTER OF THE DEADLY OUTBREAK
MEDIA REQUEST FORMIn 2014, Samaritan's Purse responded to the Ebola outbreak in Liberia by opening an Ebola treatment center—giving hands-on patient care—and
More news about: Samaritan's Purse
Jun 14, 2026, 03:15 ET Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking
More news about: Eli Lilly and Company
Jun 14, 2026, 03:00 ET Bitmine Immersion Technologies kondigt initiële dividenden en een NYSE-notering aan voor Series A Preferred Stock
onderhevig aan talrijke factoren, waarvan vele buiten de macht van Bitmine liggen, waaronder die welke zijn uiteengezet in de sectie 'Risicofactoren' van Form 10-K van Bitmine dat op 21 november 2025 is ingediend bij de SEC, evenals alle andere SEC-indieningen, zoals van tijd tot tijd gewijzigd of bijgewerkt.
More news about: Bitmine Immersion Technologies, Inc.
Jun 13, 2026, 19:32 ET Babcock & Wilcox Deadline: BW Investors Have Opportunity to Lead Babcock & Wilcox Enterprises, Inc. Securities Fraud Lawsuit
https://rosenlegal.com/submit-form/?case_id=60146 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Jun 13, 2026, 18:43 ET POET Deadline: POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
https://rosenlegal.com/submit-form/?case_id=62524 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Jun 13, 2026, 13:36 ET Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
https://rosenlegal.com/submit-form/?case_id=56548 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Jun 13, 2026, 11:15 ET Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking
More news about: Eli Lilly and Company
Jun 13, 2026, 09:00 ET Rosen Law Firm Encourages Blaize Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - BZAI
https://rosenlegal.com/submit-form/?case_id=64126 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Jun 13, 2026, 06:33 ET New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma
Johnson & Johnson's most recent Annual Report on Form 10-K, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange
More news about: Johnson & Johnson
Jun 12, 2026, 19:01 ET OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe
set out herein. For additional information with respect to risks and other factors which could occur, see OpenText's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other securities filings with the SEC and other securities regulators. Readers are cautioned not to place undue reliance upon
More news about: Open Text Corporation
Jun 12, 2026, 19:01 ET OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe
set out herein. For additional information with respect to risks and other factors which could occur, see OpenText's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other securities filings with the SEC and other securities regulators. Readers are cautioned not to place undue reliance upon
More news about: Open Text Corporation
Jun 12, 2026, 18:47 ET ADMA Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against ADMA Biologics, Inc.
form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The
More news about: Robbins LLP
Jun 12, 2026, 18:43 ET FS KKR Deadline: FSK Investors with Losses in Excess of $100K Have Opportunity to Lead FS KKR Capital Corp. Securities Fraud Lawsuit
https://rosenlegal.com/submit-form/?case_id=64089 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Jun 12, 2026, 18:41 ET GPK Investor Alert - Graphic Packaging Holding Company Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit
form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.What
More news about: Robbins LLP
Jun 12, 2026, 18:20 ET Whirlpool Announces Cash Tender Offer Early Results
these factors can be found in our periodic filings with the SEC, including our most recent Annual Report on Form 10-K, as updated by our quarterly reports on Form 10-Q, current reports on Form 8-K and other filings we make with the SEC.European Economic AreaNeither this Tender
More news about: Whirlpool Corporation
Jun 12, 2026, 17:59 ET Rosen Law Firm Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
https://rosenlegal.com/submit-form/?case_id=51887 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected]
More news about: THE ROSEN LAW FIRM, P. A.